|
π
|
The landscape of somatic copy-number alteration across human cancers
62 auth.
R. Beroukhim,
C. Mermel,
D. Porter,
G. Wei,
S. Raychaudhuri,
Jerry Donovan,
J. Barretina,
J. Boehm,
Jennifer Dobson,
M. Urashima,
Kevin T. Mc Henry,
Reid Pinchback,
A. Ligon,
Yoon-Jae Cho,
Leila Haery,
...
H. Greulich,
Michael Reich,
W. Winckler,
M. Lawrence,
B. Weir,
K. Tanaka,
Derek Y. Chiang,
A. Bass,
Alice T. Loo,
Carter Hoffman,
John R. Prensner,
T. Liefeld,
Qing Gao,
Derek W. Yecies,
S. Signoretti,
E. Maher,
F. Kaye,
H. Sasaki,
J. Tepper,
J. Fletcher,
J. Tabernero,
J. Baselga,
M. Tsao,
F. Demichelis,
M. Rubin,
P. Janne,
M. Daly,
C. Nucera,
R. Levine,
B. Ebert,
S. Gabriel,
A. Rustgi,
C. Antonescu,
M. Ladanyi,
A. Letai,
L. Garraway,
M. Loda,
D. Beer,
L. True,
A. Okamoto,
S. Pomeroy,
S. Singer,
T. Golub,
E. Lander,
G. Getz,
W. Sellers,
M. Meyerson
|
11 |
2010 |
11
π
|
|
π
|
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.
14 auth.
N. Yanaihara,
N. Caplen,
E. Bowman,
M. Seike,
K. Kumamoto,
M. Yi,
R. Stephens,
A. Okamoto,
J. Yokota,
Tadao Tanaka,
...
G. Calin,
Chang-gong Liu,
C. Croce,
C. Harris
|
11 |
2006 |
11
π
|
|
π
|
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer.
32 auth.
R. Coleman,
G. Fleming,
M. Brady,
E. Swisher,
K. Steffensen,
M. Friedlander,
A. Okamoto,
K. Moore,
Noa Efrat (Ben-Baruch),
T. Werner,
N. Cloven,
A. Oaknin,
P. DiSilvestro,
M. Morgan,
J. Nam,
...
C. Leath,
S. Nicum,
A. Hagemann,
R. Littell,
D. Cella,
Sally Baron-Hay,
J. GarcΓa-Donas,
M. Mizuno,
K. Bell-McGuinn,
D. Sullivan,
B. Bach,
Sudipta Bhattacharya,
C. Ratajczak,
P. Ansell,
M. Dinh,
C. Aghajanian,
M. Bookman
|
9 |
2019 |
9
π
|
|
π¦
|
Mutations and altered expression of p16INK4 in human cancer.
10 auth.
A. Okamoto,
D. Demetrick,
E. Spillare,
Koichi Hagiwara,
S. Hussain,
W. Bennett,
...
K. Forrester,
B. Gerwin,
M. Serrano,
D. Beach
|
9 |
1994 |
9
π¦
|
|
π¦
|
Indoleamine 2,3-Dioxygenase Serves as a Marker of Poor Prognosis in Gene Expression Profiles of Serous Ovarian Cancer Cells
14 auth.
A. Okamoto,
T. Nikaido,
K. Ochiai,
S. Takakura,
M. Saito,
Y. Aoki,
Nobuya Ishii,
N. Yanaihara,
Kyosuke Yamada,
O. Takikawa,
...
R. Kawaguchi,
S. Isonishi,
Tadao Tanaka,
M. Urashima
|
8 |
2005 |
8
π¦
|
|
π
|
Identification by cDNA microarray of genes involved in ovarian carcinogenesis.
9 auth.
K. Ono,
Toshihiro Tanaka,
T. Tsunoda,
Osamu Kitahara,
C. Kihara,
A. Okamoto,
...
K. Ochiai,
T. Takagi,
Yusuke Nakamura
|
8 |
2000 |
8
π
|
|
π
|
Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas
25 auth.
D. Etemadmoghadam,
A. Defazio,
R. Beroukhim,
C. Mermel,
J. George,
G. Getz,
R. Tothill,
A. Okamoto,
M. Raeder,
P. Harnett,
S. Lade,
L. Akslen,
A. Tinker,
Bianca Locandro,
K. Alsop,
...
Y. Chiew,
N. Traficante,
S. Fereday,
Daryl Johnson,
S. Fox,
W. Sellers,
M. Urashima,
H. Salvesen,
M. Meyerson,
D. Bowtell
|
8 |
2009 |
8
π
|
|
π
|
IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer
21 auth.
M. Anglesio,
J. George,
H. Kulbe,
M. Friedlander,
D. Rischin,
C. Lemech,
J. Power,
J. Coward,
P. Cowin,
C. House,
...
P. Chakravarty,
Kylie L. Gorringe,
I. Campbell,
A. Okamoto,
M. Birrer,
D. Huntsman,
A. De Fazio,
S. Kalloger,
F. Balkwill,
C. Gilks,
D. Bowtell
|
7 |
2011 |
7
π
|
|
π
|
Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes
45 auth.
Yi Kan Wang,
Ali Bashashati,
M. Anglesio,
D. Cochrane,
Diljot S. Grewal,
Diljot S. Grewal,
G. Ha,
A. McPherson,
A. McPherson,
Hugo M. Horlings,
J. Senz,
Leah M Prentice,
A. Karnezis,
D. Lai,
M. R. Aniba,
...
Allen W. Zhang,
Allen W. Zhang,
Allen W. Zhang,
K. Shumansky,
Celia Siu,
A. Wan,
M. McConechy,
H. Li-Chang,
A. Tone,
D. Provencher,
M. Ladurantaye,
Hubert Fleury,
A. Okamoto,
S. Yanagida,
N. Yanaihara,
M. Saito,
A. Mungall,
Richard A. Moore,
M. Marra,
M. Marra,
C. Gilks,
C. Gilks,
A. Mes-Masson,
J. McAlpine,
Samuel Aparicio,
Samuel Aparicio,
D. Huntsman,
D. Huntsman,
Sohrab P. Shah,
Sohrab P. Shah
|
7 |
2017 |
7
π
|
|
π¦
|
IS-12 Mutation and altered expression of P16^ in human cancer.
A. Okamoto,
H. Takano,
Y. Terashima,
C. Harris
|
7 |
1995 |
7
π¦
|
|
π
|
Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease
23 auth.
M. Wilson,
E. Pujade-Lauraine,
D. Aoki,
M. Mirza,
D. Lorusso,
A. Oza,
A. Bois,
I. Vergote,
A. Reuss,
M. Bacon,
...
M. Friedlander,
D. Gallardo-RincΓ³n,
F. Joly,
Suk-Joon Chang,
A. Ferrero,
R. Edmondson,
P. Wimberger,
J. MÀenpÀÀ,
D. Gaffney,
R. Zang,
A. Okamoto,
G. Stuart,
K. Ochiai
|
7 |
2017 |
7
π
|
|
π
|
Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers.
13 auth.
H. Ogiwara,
Kazuaki Takahashi,
Mariko Sasaki,
T. Kuroda,
H. Yoshida,
R. Watanabe,
Ami Maruyama,
H. Makinoshima,
F. Chiwaki,
H. Sasaki,
...
Tomoyasu Kato,
A. Okamoto,
T. Kohno
|
7 |
2019 |
7
π
|
|
π
|
Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)
28 auth.
K. Moore,
M. Bookman,
J. Sehouli,
Austin Miller,
C. Anderson,
G. Scambia,
T. Myers,
Γ. TaΕkΔ±ran,
K. Robison,
J. MÀenpÀÀ,
L. Willmott,
N. Colombo,
J. Thomes-Pepin,
M. Liontos,
M. Gold,
...
Y. Garcia,
Sudarshan K. Sharma,
C. Darus,
C. Aghajanian,
A. Okamoto,
Xiaohua Wu,
R. Safin,
Fan Wu,
L. Molinero,
V. Maiya,
V. Khor,
Yvonne G Lin,
S. Pignata
|
7 |
2021 |
7
π
|
